Metabolic consequences of interleukin-6 challenge in developing neurons and astroglia

BackgroundMaternal immune activation and subsequent interleukin-6 (IL-6) induction disrupt normal brain development and predispose the offspring to developing autism and schizophrenia. While several proteins have been identified as having some link to these developmental disorders, their prevalence is still small and their causative role, if any, is not well understood. However, understanding the metabolic consequences of environmental predisposing factors could shed light on disorders such as autism and schizophrenia.MethodsTo gain a better understanding of the metabolic consequences of IL-6 exposure on developing central nervous system (CNS) cells, we separately exposed developing neuron and astroglia cultures to IL-6 for 2 hours while collecting effluent from our gravity-fed microfluidic chambers. By coupling microfluidic technologies to ultra-performance liquid chromatography-ion mobility-mass spectrometry (UPLC-IM-MS), we were able to characterize the metabolic response of these CNS cells to a narrow window of IL-6 exposure.ResultsOur results revealed that 1) the use of this technology, due to its superb media volume:cell volume ratio, is ideally suited for analysis of cell-type-specific exometabolome signatures; 2) developing neurons have low secretory activity at baseline, while astroglia show strong metabolic activity; 3) both neurons and astroglia respond to IL-6 exposure in a cell type-specific fashion; 4) the astroglial response to IL-6 stimulation is predominantly characterized by increased levels of metabolites, while neurons mostly depress their metabolic activity; and 5) disturbances in glycerophospholipid metabolism and tryptophan/kynurenine metabolite secretion are two putative mechanisms by which IL-6 affects the developing nervous system.ConclusionsOur findings are potentially critical for understanding the mechanism by which IL-6 disrupts brain function, and they provide information about the molecular cascade that links maternal immune activation to developmental brain disorders.

[1]  Pat Levitt,et al.  Molecular Evidence for Increased Expression of Genes Related to Immune and Chaperone Function in the Prefrontal Cortex in Schizophrenia , 2007, Biological Psychiatry.

[2]  S. Mazmanian,et al.  Modeling an autism risk factor in mice leads to permanent immune dysregulation , 2012, Proceedings of the National Academy of Sciences.

[3]  O. Devinsky,et al.  Brain Biopsy Findings Link Major Depressive Disorder to Neuroinflammation, Oxidative Stress, and Neurovascular Dysfunction: A Case Report , 2014, Biological Psychiatry.

[4]  Limin Shi,et al.  Maternal Influenza Infection Causes Marked Behavioral and Pharmacological Changes in the Offspring , 2003, The Journal of Neuroscience.

[5]  R. Schwarcz,et al.  Manipulation of Brain Kynurenines: Glial Targets, Neuronal Effects, and Clinical Opportunities , 2002, Journal of Pharmacology and Experimental Therapeutics.

[6]  M. Schwarz,et al.  The role of the kynurenine metabolism in major depression , 2012, Journal of Neural Transmission.

[7]  W. Guo,et al.  Supraspinal Glial–Neuronal Interactions Contribute to Descending Pain Facilitation , 2008, The Journal of Neuroscience.

[8]  R. Dantzer,et al.  Inflammation-associated depression: From serotonin to kynurenine , 2011, Psychoneuroendocrinology.

[9]  Garth L. Maker,et al.  A review of peripheral biomarkers in major depression: The potential of inflammatory and oxidative stress biomarkers , 2014, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

[10]  P. Patterson.  Immune involvement in schizophrenia and autism: Etiology, pathology and animal models , 2009, Behavioural Brain Research.

[11]  A. Myint.  Kynurenines: from the perspective of major psychiatric disorders , 2012, The FEBS journal.

[12]  David W. Russell,et al.  LMSD: LIPID MAPS structure database , 2006, Nucleic Acids Res..

[13]  Robert Burke,et al.  ProteoWizard: open source software for rapid proteomics tools development , 2008, Bioinform..

[14]  Xiaomin Wang,et al.  TAM Receptors Affect Adult Brain Neurogenesis by Negative Regulation of Microglial Cell Activation , 2013, The Journal of Immunology.

[15]  Károly Mirnics,et al.  Immune transcriptome alterations in the temporal cortex of subjects with autism , 2008, Neurobiology of Disease.

[16]  P. Klivényi,et al.  Targeting the kynurenine pathway-related alterations in Alzheimer's disease: a future therapeutic strategy. , 2011, Journal of Alzheimer's disease : JAD.

[17]  H. Stolp.  Neuropoietic cytokines in normal brain development and neurodevelopmental disorders , 2013, Molecular and Cellular Neuroscience.

[18]  Bryson M. Brewer,et al.  Glia co-culture with neurons in microfluidic platforms promotes the formation and stabilization of synaptic contacts. , 2013, Lab on a chip.

[19]  N. Bazan,et al.  Lipid signaling: sleep, synaptic plasticity, and neuroprotection. , 2005, Prostaglandins & other lipid mediators.

[20]  D. Holtzman,et al.  Differential Effects of cAMP in Neurons and Astrocytes , 1999, The Journal of Biological Chemistry.

[21]  S. Horvath,et al.  Transcriptomic Analysis of Autistic Brain Reveals Convergent Molecular Pathology , 2011, Nature.

[22]  Deyu Li,et al.  A microfluidic cell co-culture platform with a liquid fluorocarbon separator , 2014, Biomedical microdevices.

[23]  F. Panza,et al.  Glycerophospholipids and glycerophospholipid-derived lipid mediators: a complex meshwork in Alzheimer's disease pathology. , 2011, Progress in lipid research.

[24]  K. Mirnics,et al.  Effects of maternal immune activation on gene expression patterns in the fetal brain , 2012, Translational Psychiatry.

[25]  T. Stone,et al.  Kynurenine pathway inhibition as a therapeutic strategy for neuroprotection , 2012, The FEBS journal.

[26]  Deyu Li,et al.  A versatile valve-enabled microfluidic cell co-culture platform and demonstration of its applications to neurobiology and cancer biology , 2011, Biomedical microdevices.

[27]  T. Stone.  Kynurenic acid antagonists and kynurenine pathway inhibitors , 2001, Expert opinion on investigational drugs.

[28]  O. Cauli,et al.  Interleukin 6 and cognitive dysfunction , 2014, Metabolic Brain Disease.

[29]  M Aschner,et al.  ALTERED EXPRESSION OF GENES INVOLVED IN INFLAMMATION AND APOPTOSIS IN FRONTAL CORTEX IN MAJOR DEPRESSION , 2010, Molecular Psychiatry.

[30]  Juan Hidalgo,et al.  Trans-Signaling Is a Dominant Mechanism for the Pathogenic Actions of Interleukin-6 in the Brain , 2014, The Journal of Neuroscience.

[31]  A. Ousley,et al.  Metabolic turnover of myelin glycerophospholipids , 1994, Neurochemical Research.

[32]  S. Miriuka,et al.  EDA-Containing Fibronectin Increases Proliferation of Embryonic Stem Cells , 2013, PloS one.

[33]  G. Whitesides,et al.  Poly(dimethylsiloxane) as a material for fabricating microfluidic devices. , 2002, Accounts of chemical research.

[34]  M. Schwarz,et al.  Tryptophan metabolism and immunogenetics in major depression: A role for interferon-γ gene , 2013, Brain, Behavior, and Immunity.

[35]  Derick R. Peterson,et al.  Plasma phospholipids identify antecedent memory impairment in older adults , 2014, Nature Medicine.

[36]  C. Craciunescu,et al.  Dietary Docosahexaenoic Acid Supplementation Modulates Hippocampal Development in the Pemt−/− Mouse* , 2009, The Journal of Biological Chemistry.

[37]  C. Masters,et al.  Secretion of nerve growth factor from septum stimulates neurite outgrowth and release of the amyloid protein precursor of Alzheimer's disease from hippocampal explants , 1994, Journal of neuroscience research.

[38]  R. Abagyan,et al.  METLIN: A Metabolite Mass Spectral Database , 2005, Therapeutic drug monitoring.

[39]  D. Zack,et al.  Neurite outgrowth in retinal ganglion cell culture. , 2007, Methods in molecular biology.

[40]  A. Contestabile,et al.  Neuron‐Conditioned Media Differentially Affect the Survival of Activated or Unstimulated Microglia: Evidence for Neuronal Control on Apoptotic Elimination of Activated Microglia , 2003, Journal of neuropathology and experimental neurology.

[41]  G. Oxenkrug,et al.  Tryptophan kynurenine metabolism as a common mediator of genetic and environmental impacts in major depressive disorder: the serotonin hypothesis revisited 40 years later. , 2010, The Israel journal of psychiatry and related sciences.

[42]  G. Haegeman,et al.  Interleukin-6, a mental cytokine , 2011, Brain Research Reviews.

[43]  F. Kapczinski,et al.  Neurotrophins, inflammation and oxidative stress as illness activity biomarkers in bipolar disorder , 2013, Expert review of neurotherapeutics.

[44]  G. Lundkvist,et al.  Activation of kynurenine pathway in ex vivo fibroblasts from patients with bipolar disorder or schizophrenia: cytokine challenge increases production of 3-hydroxykynurenine. , 2013, Journal of psychiatric research.

[45]  P. Patterson,et al.  Activation of the maternal immune system induces endocrine changes in the placenta via IL-6 , 2011, Brain, Behavior, and Immunity.

[46]  K. Blomgren,et al.  Brain development in rodents and humans: Identifying benchmarks of maturation and vulnerability to injury across species , 2013, Progress in Neurobiology.

[47]  B. Reizis,et al.  The role of dendritic cells in autoimmunity , 2013, Nature Reviews Immunology.

[48]  G. Whitesides,et al.  Soft lithography in biology and biochemistry. , 2001, Annual review of biomedical engineering.

[49]  Dmitry A Markov,et al.  Neurovascular unit on a chip: implications for translational applications , 2013, Stem Cell Research & Therapy.

[50]  Arthur Liberzon,et al.  Using GenePattern for Gene Expression Analysis , 2008, Current protocols in bioinformatics.

[51]  K. Mirnics,et al.  Maternal Immune Activation Alters Fetal Brain Development through Interleukin-6 , 2007, The Journal of Neuroscience.

[52]  W. T. Farmer,et al.  Midbrain dopaminergic axons are guided longitudinally through the diencephalon by Slit/Robo signals , 2011, Molecular and Cellular Neuroscience.

[53]  Abhishek Jain,et al.  Biomimetic postcapillary expansions for enhancing rare blood cell separation on a microfluidic chip. , 2011, Lab on a chip.

[54]  John P Wikswo,et al.  Microfluidic platform for real-time signaling analysis of multiple single T cells in parallel. , 2008, Lab on a chip.

[55]  T. McIntyre.  Bioactive oxidatively truncated phospholipids in inflammation and apoptosis: formation, targets, and inactivation. , 2012, Biochimica et biophysica acta.

[56]  M. During,et al.  Kynurenine metabolites of tryptophan , 1990, Neurology.

[57]  P. Patterson,et al.  Maternal influenza infection is likely to alter fetal brain development indirectly: the virus is not detected in the fetus , 2005, International Journal of Developmental Neuroscience.

[58]  Károly Mirnics,et al.  Immune System Disturbances in Schizophrenia , 2014, Biological Psychiatry.

[59]  A. Quintana,et al.  Interleukin-6, a Major Cytokine in the Central Nervous System , 2012, International journal of biological sciences.

[60]  D. Munn,et al.  Indoleamine 2,3-dioxygenase and tumor-induced tolerance. , 2007, The Journal of clinical investigation.

[61]  D. Gutmann,et al.  Neurofibromatosis-1 heterozygosity impairs CNS neuronal morphology in a cAMP/PKA/ROCK-dependent manner , 2012, Molecular and Cellular Neuroscience.

[62]  B. Agranoff,et al.  Quantitative analysis of molecular species of diacylglycerol and phosphatidate formed upon muscarinic receptor activation of human SK-N-SH neuroblastoma cells. , 1991, The Journal of biological chemistry.

[63]  Amanda J Kiliaan,et al.  Long-chain polyunsaturated fatty acids (LCPUFA) from genesis to senescence: the influence of LCPUFA on neural development, aging, and neurodegeneration. , 2014, Progress in lipid research.

[64]  S. Fedoroff,et al.  Protocols for Neural Cell Culture , 1997, Humana Press.

[65]  J. Wikswo,et al.  A dual-column solid phase extraction strategy for online collection and preparation of continuously flowing effluent streams for mass spectrometry. , 2012, Analytical chemistry.

[66]  D. Gutmann,et al.  Nucleophosmin mediates mammalian target of rapamycin-dependent actin cytoskeleton dynamics and proliferation in neurofibromin-deficient astrocytes. , 2007, Cancer research.

[67]  V. Vallyathan,et al.  Time Course of Gene Expression of Inflammatory Mediators in Rat Lung after Diesel Exhaust Particle Exposure , 2005, Environmental health perspectives.

[68]  Xiang Yang Zhang,et al.  Free radicals, antioxidant defense systems, and schizophrenia , 2013, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

[69]  Martin J. Schmidt,et al.  Immune system gene dysregulation in autism and schizophrenia , 2012, Developmental neurobiology.

[70]  Lucas H. Hofmeister,et al.  Scaling and systems biology for integrating multiple organs-on-a-chip. , 2013, Lab on a chip.

[71]  M. Schwarz,et al.  Kynurenine pathway in schizophrenia: pathophysiological and therapeutic aspects. , 2011, Current pharmaceutical design.

[72]  G. Oxenkrug.  Serotonin-kynurenine hypothesis of depression: historical overview and recent developments. , 2013, Current drug targets.

[73]  David S. Wishart,et al.  Current Progress in computational metabolomics , 2007, Briefings Bioinform..

[74]  Rodney W. Johnson,et al.  Inhibition of interleukin-6 trans-signaling in the brain facilitates recovery from lipopolysaccharide-induced sickness behavior , 2011, Journal of Neuroinflammation.